These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34753217)

  • 1. The use of pegylated interferon a-2a in a cohort of Greek patients with mycosis fungoides.
    Patsatsi A; Papadavid E; Kyriakou A; Georgiou E; Koletsa T; Avgeros C; Koumourtzis M; Lampadaki K; Tsamaldoupis A; Lazaridou E; Stratigos A; Nikolaou V
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e291-e293. PubMed ID: 34753217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Folliculotropic mycosis fungoides].
    Baratli J; Balakirski G; Megahed M
    Hautarzt; 2014 Dec; 65(12):1011-3. PubMed ID: 25355498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interferon story continues: EORTC CLTG study explores pegylated interferon α-2a's role in treating mycosis fungoides/Sézary syndrome.
    Stadler R
    Br J Dermatol; 2024 Aug; 191(3):321-322. PubMed ID: 38703059
    [No Abstract]   [Full Text] [Related]  

  • 4. Peginterferon alfa-2b for mycosis fungoides.
    Yanagi T; Shimizu T; Ujiie H; Ito M; Abe R; Tsuji-Abe Y; Hige S; Shimizu H
    Arch Dermatol; 2006 May; 142(5):649-51. PubMed ID: 16702510
    [No Abstract]   [Full Text] [Related]  

  • 5. Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon.
    Fujimura T; Okuyama R; Hashimoto A; Watanabe H; Nakagawa S; Tagami H; Aiba S
    Acta Derm Venereol; 2006; 86(2):161-2. PubMed ID: 16648924
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
    Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
    J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated liposomal doxorubicin in the treatment of mycosis fungoides.
    Lybaek D; Iversen L
    Acta Derm Venereol; 2006; 86(6):545-7. PubMed ID: 17106606
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides.
    Falkenhain-López D; Fulgencio-Barbarin J; Puerta-Peña M; Montero-Menárguez J; Sánchez-Velázquez A; Ortiz-Romero PL
    Br J Dermatol; 2022 Feb; 186(2):363-365. PubMed ID: 34528240
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
    Liu YQ; Zhu WY; Shu YQ; Gu YH
    Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides.
    Geskin LJ; Akilov OE; Schowalter MK; Falo LD
    Cancer Immunol Immunother; 2018 Jul; 67(7):1177-1178. PubMed ID: 29619509
    [No Abstract]   [Full Text] [Related]  

  • 11. Widespread comedones as the sole clinical manifestation of follicular mycosis fungoides.
    Torres T; Velho G; Alves R; Selores M
    Eur J Dermatol; 2010; 20(4):534-5. PubMed ID: 20413371
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.
    García-Vega Y; García-García I; Collazo-Caballero SE; Santely-Pravia EE; Cruz-Ramírez A; Tuero-Iglesias AD; Alfonso-Alvarado C; Cabrera-Placeres M; Castro-Basart N; Duncan-Roberts Y; Carballo-Treto TI; Soto-Matos J; Izquierdo-Toledo Y; Vázquez-Blomquist D; García-Iglesias E; Bello-Rivero I
    BMC Pharmacol Toxicol; 2012 Dec; 13():20. PubMed ID: 23272809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant leukocyte interferon alfa-2a in the treatment of mycosis fungoides.
    Simoni R; Cavalieri R; Coppola G; Ricciotti L; De Pità O; Criscuolo D; Covelli A; Papa G; Mandelli F
    J Biol Regul Homeost Agents; 1987; 1(2):93-9. PubMed ID: 3504088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated interferon-α2b for local control of Langerhans cell sarcoma.
    Ishitsuka Y; Iwamoto K; Oya K; Nakamura Y; Watanabe R; Okiyama N; Fujisawa Y; Fujimoto M
    Eur J Dermatol; 2018 Dec; 28(6):835-836. PubMed ID: 30355544
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma.
    Furudate S; Fujimura T; Kakizaki A; Hidaka T; Asano M; Aiba S
    J Dermatol Sci; 2016 Sep; 83(3):182-9. PubMed ID: 27342040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of anti-interferon alpha-2a antibody formation in patients with mycosis fungoides by exposure to long-wave UV radiation in the A range and methoxsalen ingestion.
    Kuzel TM; Roenigk HH; Samuelson E; Rosen ST
    J Natl Cancer Inst; 1992 Jan; 84(2):119-21. PubMed ID: 1735877
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides.
    Torii H; Kaneko T; Matsuyama T; Nakanishi H; Harada S
    J Dermatol; 1994 Oct; 21(10):767-70. PubMed ID: 7798436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.
    Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Nishigori C
    Eur J Dermatol; 2018 Feb; 28(1):115-116. PubMed ID: 29171409
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycosis fungoides in pregnancy: remission after treatment with alpha-interferon in a case refractory to conventional therapy: a case report.
    Echols KT; Gilles JM; Diro M
    J Matern Fetal Med; 2001 Feb; 10(1):68-70. PubMed ID: 11332424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poikilodermatous mycosis fungoides.
    Farley-Loftus R; Mandal R; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.